How do you tell if your debit card is hacked?

Written by Admin | Last Updated: July 2026

Hunter syndrome, or Mucopolysaccharidosis II (MPS II), is a rare, progressive genetic disorder caused by a deficiency in the enzyme iduronate-2-sulfatase. Because the body lacks this enzyme, glycosaminoglycans accumulate in the body's cells, leading to widespread damage. Currently, the primary treatment for Hunter syndrome is Enzyme Replacement Therapy (ERT). In this treatment, the missing or deficient enzyme is administered intravenously on a weekly basis. This helps reduce the accumulation of glycosaminoglycans and can alleviate some of the physical symptoms, such as an enlarged liver or spleen, and improve joint mobility and respiratory function. However, ERT typically does not cross the blood-brain barrier effectively, meaning it has limited impact on the neurological symptoms associated with the severe form of the disease. Other supportive care strategies are essential, including physical and occupational therapy to maintain joint range of motion, speech therapy, and surgical interventions to address specific complications like airway obstructions or heart valve issues. Bone marrow transplantation or hematopoietic stem cell transplantation is another potential treatment pathway, which may offer more significant benefits in certain patients if performed early, but these carry substantial risks. Management of Hunter syndrome is complex and requires a multidisciplinary medical team, including geneticists, pediatricians, neurologists, and cardiologists, to tailor a treatment plan to the specific needs of the patient, as ongoing research into gene therapy and other novel approaches continues to offer hope for future improvements in care.

Related FAQs

Yes, the Bank of Ireland (BOI) imposes daily limits on various transactions, including cash withdrawals at ATMs, digital funds transfers, and point-of-sale payments, to ensure security and manage operational risk.

Yes, BOK Financial Corporation (BOKF) owns the Bank of Texas. Bank of Texas operates as a primary subsidiary of BOK Financial, which is a major regional financial services company headquartered in Oklahoma.

Financial institutions monitor cash withdrawals under internal risk guidelines and anti-fraud frameworks rather than a secret cutoff number.